Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Bausch Health Companies Inc. | a58127e8vk.htm |
| EX-10.1 - EX-10.1 - Bausch Health Companies Inc. | a58127exv10w1.htm |
| EX-10.2 - EX-10.2 - Bausch Health Companies Inc. | a58127exv10w2.htm |
Exhibit 99.1
International Headquarters
7150 Mississauga Road
Mississauga, Ontario L5N 8M5
Phone: 905.286.3000
Fax: 905.286.3050
7150 Mississauga Road
Mississauga, Ontario L5N 8M5
Phone: 905.286.3000
Fax: 905.286.3050
Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com
Laurie W. Little
949-461-6002
laurie.little@valeant.com
VALEANT PHARMACEUTICALS ANNOUNCES
APPOINTMENT OF ROBERT A. INGRAM AND
RESIGNATION OF WILLIAM M. WELLS AS CHAIRMAN
APPOINTMENT OF ROBERT A. INGRAM AND
RESIGNATION OF WILLIAM M. WELLS AS CHAIRMAN
Mississauga, Ontario, December 13, 2010 — Valeant Pharmaceuticals International, Inc. (NYSE:
VRX) (TSX: VRX) today announced that Robert A. Ingram, Valeant’s lead independent director, was
appointed as Chairman of the Board of Directors, replacing William M. Wells, who has resigned from
the Board to pursue other interests.
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty
pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical
products primarily in the areas of neurology, dermatology and branded generics. More information
about Valeant can be found at www.valeant.com.
###